Health3 years ago
Monoclonal antibody therapy combo effective against mild to moderate covid: study
New Delhi : The combination of casirivimab and imdevimab (two monoclonal antibody treatments) keeps high-risk patients away from the hospital when infected with mild to moderate...
Recent Comments